BridgeMD
New treatment option for Infant, Premature, Diseases
Official title Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants
ClinicalTrials.gov ID: NCT07216664
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if the multisensory early oral administration of human milk (M-MILK) intervention helps infants who are born younger than 32 weeks gestational age (very preterm infants). The main question that this clinical trial aims to answer is: Does M-MILK improve stress regulation, support optimal neurodevelopment, and promote competent oral feeding skills in very preterm infants?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 23 to 32
You may be able to join if
- Born at ≤ 32 weeks gestational age.
- Receiving mother's own milk and/or donor human milk at the time of screening.
You likely can't join if
- Receiving only formula.
- Gastrointestinal defects, i.e., cleft lip or cleft palate.
- Congenital cardiac defects requiring surgery.
- Necrotizing enterocolitis.
- Chromosomal abnormalities.
The study team makes the final eligibility decision.
Where it's taking place
- Maywood, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 23 weeks to 32 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Maywood, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.